References
- Simundic AM, Nikolac N, Vukasovic I, et al. The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory. Clin Chem Lab Med. 2010;48:1009–1014.
- Lippi G, Bassi A, Brocco G, et al. Preanalytic error tracking in a laboratory medicine department: results of a 1-year experience. Clin Chem. 2006;52:1442–1443.
- Dolci A, Panteghini M. Harmonization of automated hemolysis index assessment and use: is it possible? Clin Chim Acta. 2014;432:38–43.
- Lippi G, Banfi G, Buttarello M, et al. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin Chem Lab Med. 2007;45:728–736.
- Lippi G, Cadamuro J, von Meyer A, et al. European federation of clinical chemistry and laboratory medicine (EFLM) working group for preanalytical phase (WG-PRE). Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med. 2018;56:718–727.
- Lippi G. Systematic assessment of the hemolysis index: pros and cons. Adv Clin Chem. 2015;71:157–170.
- Lippi G, Plebani M. Continuous-flow automation and hemolysis index: a crucial combination. J Lab Autom. 2013;18:184–188.
- Simundic AM, Topic E, Nikolac N, et al. Hemolysis detection and management of hemolyzed specimens. Biochem Med. 2010;20:154–159.
- Lippi G, Plebani M, Di Somma S, et al. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci. 2011;48:143–153.
- Lippi G, Blanckaert N, Bonini P, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med. 2008;46:764–772.
- Phelan MP, Reineks EZ, Schold JD, et al. Preanalytic factors associated with hemolysis in emergency department blood samples. Arch Pathol Lab Med. 2018;142:229–235.
- Cadamuro J, Fiedler GM, Mrazek C, et al. In-vitro hemolysis and its financial impact using different blood collection systems. J Lab Med. 2016;40:49–55.
- Ricos C, Alvarez V, Cava F, et al. Current databases on biologic variation: pros, cons and progress. Scand J Clin Lab Invest. 1999;59:491–500. The 2014 update. [cited 2018 Dec 6]. Available from: https://www.westgard.com/biodatabase1.htm.
- Beckman Coulter Technical documents. [cited 2018 April 13]. Available form: https://www.beckmancoulter.com/wsrportal/page/techdocSearch.
- Koseoglu M, Hur A, Atay A, et al. Effects of hemolysis interferences on routine biochemistry parameters. Biochem Med (Zagreb). 2011;21:79–85.
- Lippi G, Salvagno GL, Montagnana M, et al. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med. 2006;44:311–316.
- Dimeski G. Interference testing. Clin Biochem Rev. 2008;29:S43–S48.
- Clinical Laboratory Standards Institute (CLSI). Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline. CLSI C56-A document. Wayne (PA): CLSI; 2012.
- Clinical Laboratory Standards Institute (CLSI). Interference testing in clinical chemistry; approved guideline. CLSI EP7-A2 document. Wayne (PA): CLSI; 2005.